Larvol Delta - RESPIRE-Clinical-Trial-to-Evaluate-the-Safety-and-Efficacy-of-ATR002-in-Adult-Hospitalized-Patients-With-COVID19

zapnometinib (ATR-002) - Atriva Therap

http://clinicaltrials.gov/ct2/show/NCT04776044

Jun 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next